Unjha Formulations Ltd.
BSE: 531762 | Sector: Health care |
NSE: N.A. | ISIN Code: INE576D01015 |
BSE 16:01 | 01 Mar | 7.98 |
0.38 (5.00%) |
OPEN
7.25 |
HIGH
7.98 |
LOW
7.25 |
NSE 05:30 | 01 Jan | Unjha Formulations Ltd Not listed in NSE |
OPEN | 7.25 |
PREVIOUS CLOSE | 7.60 |
VOLUME | 4800 |
52-Week high | 10.26 |
52-Week low | 5.20 |
P/E | 49.88 |
Mkt Cap.(Rs cr) | 4 |
Buy Price | 7.23 |
Buy Qty | 10.00 |
Sell Price | 7.98 |
Sell Qty | 497.00 |
About Unjha Formulations Ltd.
Unjha Formulations was established in Jun.'87 as a partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat. It was promoted by Shambhubhai A Patel.The company manufactures pharmaceutical formulations like liquids powder tablets capsules injectibles etc. It is one of the largest manufacturers of isabgul products in India. The company's products are classifi...> More
Unjha Formulations Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
4 | |
EPS - TTM | (![]() |
[*S] | 0.16 |
P/E Ratio | (X) | [*S] | 49.88 |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | - | |
Latest Dividend Date | - | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 5.01 |
P/B Ratio | (![]() |
[*S] | 1.59 |
Announcement
-
Un-Audited Finacial Results For Quater And Nine Month Ended As On 31.12.2020 Inclu Limited Review Fr
-
Board Meeting Intimation for Board Meeting - Date: 06.02.2021 ( Un-Audited Financial Results For The
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
-
Statement Of Investor Complaints For The Quarter Ended December 2020
Unjha Formulations Ltd - Financial Results
Particulars (![]() |
Dec 2020 | Dec 2019 | % Chg |
Net Sales | 2.52 | 2.24 | 12.5 |
Other Income | 0.05 | 0.04 | 25 |
Total Income | 2.58 | 2.28 | 13.16 |
Total Expenses | 2.62 | 2.24 | 16.96 |
Operating Profit | -0.05 | 0.04 | -225 |
Net Profit | -0.07 | 0.02 | -450 |
Equity Capital | 4.48 | 4.48 | - |
Unjha Formulations Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Veerhealth Care | 8.90 | 4.71 | 6.17 |
Guj. Terce Labs. | 8.00 | -1.23 | 5.94 |
Colinz Labs | 8.40 | -1.52 | 3.84 |
Unjha Formul. | 7.98 | 5.00 | 3.58 |
Beryl Drugs | 6.51 | -4.96 | 3.30 |
Chemo Pharma Lab | 21.60 | -1.82 | 3.24 |
Bacil Pharma | 5.27 | -4.18 | 3.10 |
Unjha Formulations Ltd - SHAREHOLDING PATTERN
|
|
Unjha Formulations Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -4.89% | NA | 0.21% | 0.58% |
1 Month | -18.07% | NA | 2.57% | 3.36% |
3 Month | 6.40% | NA | 11.63% | 12.61% |
6 Month | 6.40% | NA | 28.15% | 28.69% |
1 Year | 22.39% | NA | 30.17% | 31.78% |
3 Year | NA | NA | 46.42% | 41.15% |
Unjha Formulations Ltd - STOCK STRENGTH
Today's Low/High | 7.25 | 7.98 | |
Week Low/High | 7.25 | 8.00 | |
Month Low/High | 7.25 | 10.00 | |
YEAR Low/High | 5.20 | 10.00 | |
All TIME Low/High | 1.00 | 35.00 |
Quick Links for Unjha Formulations:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices